roid volume after thyroidectomy [9] . For measurement of RAIU, all patients ingested 2 capsules that contained 7.4 MBq of 123 I. RAIU was measured with a scintillation probe with a NaI crystal (E.CAM, Toshiba Medical Systems Corp., Tochigi, Japan) at a distance of 15 cm from the thyroid. Radiation from a 123 I standard that was placed in a thyroid uptake phantom was counted for 20 seconds. The 123 I standard was the same volume and activity as the dose administered to the patients. Patients were counted with the scintillation probe for 20 seconds at both 3 and 24 hours after 123 I ingestion. The thyroid 123 I uptake value was calculated using the following equation: RAIU (%) = (neck count -background) / (standard count -background) × 100.
Statistical Analysis
Forward-backward stepwise multiple regression analyses were performed to investigate factors that could be used to predict 24-hour RAIU. Factors investigated were gender, age, thyroid volume, TSH, FT4, FT3, serum creatinine (Cre), TRAb2, ATD discontinuation period (ADP), iodine restriction period and 3-hour RAIU. For multiple regression analyses, ADP was assigned as follows: 3 days, 4 days, 5 days, 6 days, and either 7 or more days or no ATD administration were assigned to scores of 0, 1, 2, 3 and 4, respectively. The ADP score (ADPS) was included in the model. Before multiple regression analyses, a logarithmic transformation was performed for variables with nonnormal distributions in order to fit the data into a normal distribution. Normal distribution was tested with the Shapiro-Wilk test. A P-value <0.05 was considered statistically significant. All data with normal distributions were expressed as mean ± standard deviation (SD) and all data with non-normal distributions were expressed as median ± interquartile range (IQR). All statistical analyses were performed using SPSS version 16.0 software (SPSS Japan, Tokyo, Japan). Table 1 shows clinical characteristics of the 66 patients with Graves' disease. Twenty-four-hour RAIU values were greater than 3-hour RAIU values in all patients. TRAb1 values of 9 patients were converted to TRAb2 values by the aforementioned equation [8] . Fig. 1 shows the relationship between 3-hour and 24-hour RAIU analyzed by simple regression analyses (r = 0.70, P < 0.001, Fig. 1 ). As shown in Table 2 , mulAssociation guideline for diagnosis of Graves' disease [5] . Treatment with antithyroid drugs (ATD) such as methimazole (MMI) and propylthiouracil (PTU) was discontinued for at least 3 days before RAIU measurement [6] . Dietary iodine restriction was initiated at least 3 days before RAIU measurement [7] . Dietary iodine restriction was performed through avoidance of the following foods: seaweed, seaweed soup and iodinated eggs. Patients who had received RI therapy or thyroidectomy were included in the present study. Of the 75 patients with Graves' disease who had undergone both 3-hour and 24-hour 123 I RAIU measurements, 9 patients were excluded for the following two reasons: either dietary iodine restriction was continued for only 1 day (n = 3) or ATD was administered between diagnostic 3-hour RAIU measurement and RI therapeutic 24-hour RAIU measurement because adverse effects from ATD treatment required a change in treatment from ATD to RI therapy (n = 6). A total of 66 patients (14 men and 52 women; age, 17-83 years) were included in the present analyses. These 66 patients included 4 patients who had received RI therapy and 2 patients who had received thyroidectomy.
Results

Measurements
Thyroid function was assessed by measuring serum free triiodothyronine (FT3) ("Vitros" FT3II kit, OrthoClinical Diagnostics K.K., Tokyo, Japan; reference range, 2.35-4.48pg/mL), free thyroxine (FT4) ("Vitros" FT4 kit, Ortho-Clinical Diagnostics; reference range, 0.81-1.58ng/dL) and TSH ("Vitros" TSH kit, OrthoClinical Diagnostics; reference range, 0.46-4.68μIU/ mL). TSH binding inhibitory immunoglobulin (TBII) was measured by either a TSH receptor antibody (TRAb) first generation assay kit (TRAb "Cosmic" III, Cosmic Corp., Tokyo, Japan) or a TRAb second generation assay kit (DYNO test TRAb Human kit "YAMASA", Yamasa Corp., Tokyo, Japan). For statistical analyses, the first generation TRAb (TRAb1) value was converted to the second generation TRAb (TRAb2) value using the following equation: TRAb2 = TRAb1 × 0.30 + 0.16 [8] . Thyroid volume was measured as reported previously [9] . Maximum width (W), maximum thickness (T) and maximum length (L) were measured in both right (r) and left (l) lobes of the thyroid gland. Thyroid volume was calculated by the following equation: thyroid volume = (rW × rT × rL + lW × lT × lL) × 0.70. The factor 0.7 was obtained by the comparison of thyroid volume measured by this method and actual thy-= 0.156) and iodine restriction period (P = 0.733), were not statistically significant predictive factors of 24-hour RAIU. The relationship between 24-hour RAIU (LU), 3-hour RAIU (EU), FT3 and ADPS was as follows: LU = 11.5 + 29.1 × log 10 EU + 23.0 × log 10 FT3 -2.7 × ADPS (r = 0.82, P < 0.001, Fig. 2 ).
tiple regression analyses revealed that 3-hour RAIU (P < 0.001), FT3 (P < 0.001) and ADPS (P < 0.001) were statistically significant predictive factors of 24-hour RAIU. All other factors, including gender (P = 0.266), age (P = 0.452), thyroid volume (P = 0.291), TSH (P = 0.497), FT4 (P = 0.096), Cre (P = 0.282), TRAb2 (P discussion Table 3 compares the present early-to-late RAIU conversion equation and several other early-to-late RAIU conversion equations that have been previously reported by other investigators [1, 3, 4] . These previously reported equations suggest a stronger correlation between early RAIU and late RAIU than the present equation, which employs only 3-hour RAIU. However, the present equation, which employs 3-hour RAIU, FT3 and ADPS, suggests a correlation between early RAIU and late RAIU that is as strong as the other authors' equations. Reasons for the differences in strength of correlation between early and late RAIU are uncertain, but could be attributable to the time of the early RAIU measurement, to iodine intake before RAIU measurement, or to ethnicity.
Several other investigators have reported that patients with hyperthyroidism or Graves' disease have "rapid turnover" (24-hour RAIU value is less than the 3-to 4-hour RAIU value; typically characterized by a significantly increased early RAIU value) [3, 4, 10, 11] . Furthermore, Marcocci et al. [10] and Atkay et al. [11] reported that rapid turnover is a statistically significant predictor of RI therapy failure because of rapid clearance or turnover of RI from the thyroid gland. RI therapy failure rates were reported to be 55% in 87 Graves' disease patients and 48% in 67 hyperthyroidism patients with rapid turnover, compared to 21% in 187 Graves' disease patients and 11% in 366 hyperthyroidism patients without rapid turnover [10, 11] . The prevalence of rapid turnover was reported to be 32% in 274 patients with Graves' disease by Marcocci et al. [10] , 15% in 433 patients with hyperthyroidism (including 379 patients with Graves' disease) by Atkay et al. [11] , 17% in 69 patients with Graves' disease by Vemulakonda et al. [3] , and 12% in 148 patients with Graves' disease by Morris et al. [4] . In the present study, none of the patients with Graves' disease had rapid turnover. Morris et al. [4] also reported that Graves' disease patients with 4-hour RAIU values of 77% or greater also should obtain 24-hour RAIU values, probably due to rapid turnover. However, only 7 of 66 patients had 3-hour RAIU values greater than 77% in the present study, and none of those 7 patients had rapid turnover. The reasons for these differences in rates of rapid turnover are uncertain, but they could be attributable to iodine intake before RAIU measurement or to ethnicity.
In the present multiple regression equation, an increase in the ADP resulted in a decrease of the predictive 24-hour RAIU value. Kubota et al. [6] reported that 2-day ATD discontinuation sufficiently increased the 24-hour RAIU. Therefore, an increase in the ADP may not decrease the 24-hour RAIU, but may increase the 3-hour RAIU compared to the 24-hour RAIU. Atkay et al. [11] also estimated that administration of ATD may alter RI thyroidal kinetics and increase RI turnover. In the present study, 35 of the 66 patients with Graves' disease had received ATD, but none of the patients exhibited rapid turnover. The relationship between ATD administration and rapid turnover remains controversial.
In the present study, multiple regression analyses showed that not only 3-hour RAIU but also FT3 and ADPS were statistically significant predictive factors of 24-hour RAIU. The present study included only 14 men with Graves' disease, and no patients with rapid turnover were observed. Therefore, further studies may be required to determine a more accurate equation for prediction of 24-hour RAIU.
In conclusion, the present results in Japanese patients with Graves' disease indicate that unless patients have rapid turnover, prediction of 24-hour RAIU using 3-hour RAIU, FT3 and ADPS is feasible. With this prediction equation both measurement of RAIU and calculation of the RI therapy dose can be achieved in a single day.
